Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEAL: Enoxaparin in Chest Pain Syndrome
NCT00518245Phase 4Terminated
- Sponsor
- Canadian Heart Research Centre
- Start
- Aug 2007
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in unstable angina, sponsored by Canadian Heart Research Centre. Started Aug 2007; status: terminated.
02
Drugs
enoxaparin
03
Conditions
unstable angina
Beyond the preview
Go deeper on NCT00518245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518245.